J. Januzzi

Journal of the American College of Cardiology · 2005–2021

A researcher in the Science corpus: 18 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Who trusts J. Januzzi overall

  1. M. Gheorghiade

Papers from J. Januzzi's perspective

Ordered by how strongly the researchers J. Januzzi trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. (New England Journal of Medicine)
  2. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. (The Lancet)
  3. Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the Community (Circulation)
  4. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. (Journal of the American Medical Association (JAMA))
  5. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry… (Journal of the American College of Cardiology)
  6. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. (Journal of the American College of Cardiology)
  7. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. (Journal of the American College of Cardiology)
  8. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. (Journal of the American Medical Association (JAMA))
  9. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. (Journal of the American Medical Association (JAMA))
  10. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. (Journal of the American Medical Association (JAMA))

Their papers